New chikungunya vaccine trial aims to protect millions
NCT ID NCT07555392
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new vaccine called BBV87 to see if it can safely protect people from chikungunya, a virus spread by mosquitoes that causes fever and joint pain. About 1000 healthy volunteers aged 12 to 65 will receive the vaccine and be monitored for side effects and immune response. The goal is to find out if the vaccine triggers enough antibodies to prevent infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE IMMUNISATION FOR CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AIIMS Rishikesh Department of Community Medicine
NOT_YET_RECRUITINGRishikesh, Uttarakhand, 249203, India
-
All India Institute of Medical Sciences
NOT_YET_RECRUITINGGuwahati, Assam, 7811101, India
-
All India Institute of Medical Sciences
NOT_YET_RECRUITINGPatna, Bihar, 801507, India
-
All India Institute of Medical Sciences
NOT_YET_RECRUITINGRaipur, Chhattisgarh, 492099, India
-
Guru Teg Bahadur Hospital
RECRUITINGDelhi, The National Capital Territory (nct) of Delhi, 110029, India
-
IMS & SUM Hospital bhubaneshwar Institute of Medical Sciences & SUM Hospital
RECRUITINGBhubaneswar, Odisha, 751003, India
-
Jawahar Lal Nehru medical College
NOT_YET_RECRUITINGAjmer, Rajasthan, 305001, India
-
PGIMS
NOT_YET_RECRUITINGRohtak, Haryana, 124001, India
-
Redkar Hospital and Research Centre
RECRUITINGMumbai, Goa, 403513, India
-
Sardar Patel Medical College
NOT_YET_RECRUITINGBikaner, Rajasthan, 334001, India